Acquired MET Expression Confers Resistance to EGFR Inhibition In a Mouse Model of Glioblastoma Multiforme

Glioblastoma Multiforme (GBM) is an aggressive brain tumor for which there is no cure. Overexpression of wild-type EGFR and loss of the tumor suppressor genes Ink4a/Arf and PTEN are salient features of this deadly cancer. Surprisingly, targeted inhibition of EGFR has been clinically disappointing, d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jun, Hyun Jung, Acquaviva, Jaime, Chi, Dorcas, Lessard, Julie, Zhu, Haihao, Woolfenden, Steve, Bronson, Roderick T., Pfannl, Rolf, White, Forest, Housman, David E., Iyer, Lakshmanan, Whittaker, Charles A., Boskovitz, Abraham, Raval, Ami, Charest, Alain
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3774279/
https://ncbi.nlm.nih.gov/pubmed/22020333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2011.474
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars